Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PRF for healing after impacted mandibular third molar surgery
2019-000902-31Phase 3Active
- Sponsor
- Omequi
- Start
- Jul 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of Platelet-Rich Fibrin in postoperative pain, post-operative inflammation, impaired surgical wound healing and 1 more (2 arms), sponsored by Omequi. Primary endpoint: Intensity of postoperative pain. Started Jul 2019; status: active.
02
Drugs
Platelet-Rich Fibrin
03
Conditions
postoperative painpost-operative inflammationimpaired surgical wound healingalveolar osteitis (AO)
Beyond the preview
Go deeper on 2019-000902-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000902-31.